Abstract

One of the biochemical indicators objectively characterizing the state of hemostasis is the level of fibrin and fibrinogen cleavage products in blood, which are formed, as a rule, as a result of intravascular fibrin formation with simultaneous or subsequent activation of fibrinolytic system, accompanied by appearance of proteolytic enzyme plasmin. Plasmin splits (degrades) the formed fibrin or (to a lesser extent) fibrinogen, which leads to the appearance of more or less large protein "fragments" in the bloodstream, called products of fibrin degradation. Some of them are unable to clot and can be detected in serum after clot separation. Thus, the detection of fibrin degradation products always indicates intravascular activation of hemocoagulation and fibrinolysis systems.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.